Fluorouracil/folinic acid companion diagnostic - Allarity Therapeutics
Alternative Names: DRP-5-fluorouracil; DRP®-5FULatest Information Update: 08 Sep 2023
At a glance
- Originator Allarity Therapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Colorectal cancer